Literature DB >> 7293874

Impaired cell-mediated immunity in patients with kala-azar.

L Hepner Levy, E Mendes.   

Abstract

Delayed hypersensitivity by intracutaneous tests with leishmanin, tuberculin, trichophytin, oidiomycin, as well as sensitization with DNCB were assessed in ten patients with kala-azar. There was a significant depression of delayed hypersensitivity to leishmanin (Montenegro reaction) during the active phase of the disease. The response to ubiquitous microbial antigens and DNCB were also depressed as compared to controls.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7293874

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN： 0301-0546            Impact factor:   1.667


  7 in total

1.  Antileishmania immunological tests for asymptomatic subjects living in a visceral leishmaniasis-endemic area in Brazil.

Authors:  Luciana Almeida Silva; Héctor Dardo Romero; Gabriel Antônio Nogueira Nascentes; Roberto Teodoro Costa; Virmondes Rodrigues; Aluízio Prata
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

2.  Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains.

Authors:  O M Ulczak; E Ghadirian; E Skamene; J M Blackwell; P A Kongshavn
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  A Subset of Neutrophils Expressing Markers of Antigen-Presenting Cells in Human Visceral Leishmaniasis.

Authors:  Smriti Sharma; Richard E Davis; Shweta Srivastva; Susanne Nylén; Shyam Sundar; Mary E Wilson
Journal:  J Infect Dis       Date:  2016-09-06       Impact factor: 5.226

4.  Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  J P Haldar; S Ghose; K C Saha; A C Ghose
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

5.  Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: T-lymphocyte-mediated immunosuppression.

Authors:  A D Nickol; P F Bonventre
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

6.  Immunosuppression in Kenyan visceral leishmaniasis.

Authors:  M Ho; D K Koech; D W Iha; A D Bryceson
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

7.  Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.

Authors:  E M Carvalho; O Bacellar; A Barral; R Badaro; W D Johnson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.